Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.43 |
| ▸ | F2 | P00734 | 4/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
| ▸ | CALCR | P30988 | 3/20 | 0.40 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.40 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.40 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.40 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5367479 | 0.86 | F2 (0.42) | F2NTSR1CALCRREN | |
| SCHEMBL5367473 | 0.82 | PTPN1 (0.41) | PTPN1F2NTSR1REN | |
| SCHEMBL20888357 | 0.80 | REN (0.40) | PTPN1NTSR1REN | |
| SCHEMBL29814609 | 0.79 | REN (0.41) | F2NTSR1CXCR4REN | |
| SCHEMBL31321048 | 0.79 | REN (0.45) | NTSR1REN | |
| SCHEMBL11910884 | 0.78 | NTSR1 (0.43) | F2NTSR1CALCRNMUR2NMUR1 | |
| SCHEMBL29814390 | 0.78 | APLNR (0.46) | F2NTSR1CXCR4 | |
| SCHEMBL31558763 | 0.78 | F2 (0.46) | F2NTSR1REN | |
| SCHEMBL29814358 | 0.77 | CALCR (0.41) | F2NTSR1CALCR | |
| SCHEMBL5367237 | 0.77 | CXCR4 (0.48) | CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109420179-B | Docetaxel targeted prodrug and anti-colon cancer medicinal application thereof | 复旦大学 | 2022-08-26 | — | — | CN | disclosed |